NCT04149613View on ClinicalTrials.gov

Predictive and Prognostic Value of Inflammatory Markers and microRNA in Stage IV Colorectal Cancer

Enrolling by invitationOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

May 25, 2018

Primary Completion Date

July 15, 2025

Study Completion Date

July 15, 2026

Conditions

Colorectal Cancer Stage IV

Trial Locations (1)

Unknown

American University of Beirut, Beirut

All Listed Sponsors

lead

American University of Beirut Medical Center

OTHER